Scopolamine NDC 50742-505

NDC codes

FDA NDC Directory

Product NDC (as listed)50742-505Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50742-0505Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
50742-505-04	50742050504	4 POUCH in 1 CARTON (50742-505-04) / 1 PATCH, EXTENDED RELEASE in 1 POUCHMarketed from Nov 24, 2020
50742-505-10	50742050510	10 POUCH in 1 CARTON (50742-505-10) / 1 PATCH, EXTENDED RELEASE in 1 POUCHMarketed from Nov 24, 2020
50742-505-24	50742050524	24 POUCH in 1 CARTON (50742-505-24) / 1 PATCH, EXTENDED RELEASE in 1 POUCHMarketed from Nov 24, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Scopolamine
Generic name (nonproprietary): scopolamine
Active ingredients: Scopolamine — 1.5 mg/1
Dosage form: Patch, Extended release
Route: Transdermal
Labeler: Ingenus Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212342
Marketing start: Nov 24, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Antagonists (Mechanism)
Identifiers: Product ID 50742-505_3baa2417-8daa-4253-89a4-fef4be344fc1SPL ID 3baa2417-8daa-4253-89a4-fef4be344fc1SPL set ID 2a6f9aaf-a70a-481f-a82b-1dcaaadc185bRxCUI 226552UNII DL48G20X8X
Pharmacologic class: Anticholinergic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450742050504 followed by a unit qualifier and the quantity

Package 50742-0505-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 9, 2026.

Indications (excerpt from the label)

Scopolamine transdermal system is indicated in adults for the prevention of: nausea and vomiting associated with motion sickness. post-operative nausea and vomiting (PONV) associated with recovery from anesthesia and/or opiate analgesia and surgery. Scopolamine transdermal system is an anticholinergic indicated in adults for the prevention of: nausea and vomiting associated with motion sickness. ( 1 ) post-operative nausea and vomiting (PONV) associated with recovery from anesthesia and/or opiate analgesia and surgery. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212342

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212342
Product	Strength	Form · route	Labeler	Product NDC
Scopolamine	Scopolamine 1.5 mg/1	Patch, Extended releaseTransdermal	NuCare Pharmaceuticals, Inc.	68071-3994